Short-interference RNAs: becoming medicines

Authors

  • Tamara Martínez Sylentis, R&D department c/Santiago Grisolía, Tres Cantos, Madrid, Spain
  • Ana Isabel Jiménez Sylentis, R&D department c/Santiago Grisolía, Tres Cantos, Madrid, Spain
  • Covadonga Pañeda Sylentis, R&D department c/Santiago Grisolía, Tres Cantos, Madrid, Spain

DOI:

https://doi.org/10.17179/excli2015-297

Keywords:

siRNA, RNAi, oligonucleotides, therapeutics

Abstract

RNA interference is a cellular mechanism by which small molecules of double stranded RNA modulate gene expression acting on the concentration and/or availability of a given messenger RNA. Almost 10 years after Fire and Mello received the Nobel Prize for the discovery of this mechanism in flat worms, RNA interference is on the edge of becoming a new class of therapeutics. With various phase III studies underway, the following years will determine whether RNAi-therapeutics can rise up to the challenge and become mainstream medicines. The present review gives a thorough overview of the current status of this technology focusing on the path to the clinic of this new class of compounds.

Downloads

Published

2015-06-15

How to Cite

Martínez, T., Jiménez, A. I., & Pañeda, C. (2015). Short-interference RNAs: becoming medicines. EXCLI Journal, 14, 714–746. https://doi.org/10.17179/excli2015-297

Issue

Vol. 14 (2015)

Section

Original articles

License

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).